检索结果 - Martin Guillot

  • Showing 1 - 1 results of 1
Refine Results
  1. 1
    Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture

    Nonclinical cardiovascular safety evaluation of romosozumab, an inhibitor of sclerostin for the treatment of osteoporosis in postmenopausal women at high risk of fracture 由 James R. Turk, Aimée M. Deaton, Jun Yin, Marina Stolina, Melanie Felx, Gabrielle Boyd, Jean-Guy Bienvenu, Aurore Varela, Martin Guillot, Gill Holdsworth, Alison Wolfreys, Denise Dwyer, Sheetal Kumar, Emily M. de Koning, Yusheng Qu, Michael J. Engwall, Kathrin Locher, Lucas D. Ward, Charles Glaus, Yudong D. He, Rogely Boyce

    出版 2020
    获取全文
    Artigo
    加到收藏夹
    Saved in:

检索工具: